KT-333

KT-333 · Kymera Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KT-333, covering 2025-03-19 to 2025-03-19. Get the full timeline:

Most recent: Clinical Trial Update: Safety, PK, PD, Clinical Activity of KT-333 in Adult Patients With Refractory Lymphoma, Large Granular Lymphocytic Leukemia, Solid Tumors [Phase 1]

See pricing